TP53 and cancer: Thus, our findings add to the complexity of p21 functions and lend credence to the cautionary note made by us [17] and Warfel and El-Deiry [20] that a greater insight into the molecular and biological consequences associated with p21 loss is crucial to determining whether modulating p53–p21 signaling might be a promising approach for the treatment of certain types of cancers.